SARS-CoV-2 infections in people with PCD: neither frequent, nor particularly severe

Abstract

People with pre-existing chronic health conditions are reportedly at high risk of getting the coronavirus disease (COVID-19) and of having a severe disease course but little data exist on rare diseases such as Primary Ciliary Dyskinesia (PCD). We studied risk and severity of SARS-CoV-2 infections among people with PCD using data from the COVID-PCD, a participatory study that collects data in real-time directly from people with PCD. Data was collected using online questionnaires. A baseline questionnaire collected information on demographic data, information about the PCD diagnosis and severity. A short weekly questionnaire collected information about current symptoms and incident SARS-CoV-2 infections. 578 people participated in the COVID-PCD by December 7, 2020, with a median number of follow-up weeks of 9 (interquartile range: 4-19 weeks). 256 (45%) of the participants had been tested for SARS-CoV-2 and 12 tested positive prior to study entry or during study follow up (2.1% of the total included population, 95% confidence interval (CI) 1.1-3.6%). 4 people tested positive during the study follow-up, corresponding to an incidence rate of 2.5 per 100 person-years (95% CI: 0.9-6.5). Overall, reported severity was mild with two reporting no symptoms, eight reporting mild symptoms, one reporting severe symptom without hospitalisation, and one reporting hospitalisation for 9 days. The study suggests that with careful personal protection, people with PCD do not seem to have an increased risk of infection with SARS-COV-2, nor an especially severe disease course.Take home messageIn this longitudinal study of people with PCD followed weekly via online questionnaires, the incidence rate of COVID-19 and the proportion of participants infected were low, and the observed severity mostly mild.

Chronic respiratory diseases other than asthma in children: the COVID-19 tsunami

“…It has been speculated that this could be explained by the under-diagnosis of CRD in some countries in comparison to other chronic diseases, as well as by a deep commitment from patients and parents in practicing careful protective behaviors in order to avoid respiratory infections. In fact, these patients and their families are inevitably more prone to careful personal protection due to consolidated experience in hand hygiene, mask wearing, and social distancing [34][35][36]. Some authors suggest that CRD treatments may reduce the risk of infection or developing COVID-19, such as the chronic administration of azithromycin [37] and inhaled corticosteroids (ICS).…”

Facemask usage during the COVID-19 pandemic among people with primary ciliary dyskinesia: a participatory project

“…COVID-PCD is a participatory research project where people with PCD have an active role in all stages of research from the design of the study, its content, the piloting, and communication of results. Details about the study methods have been published [24, 25]. In short, the COVID-PCD study includes persons of any age from anywhere in the world with a confirmed or suspected diagnosis of PCD.…”

Association between smoking and COVID-19 severity: A multicentre retrospective observational study

“…[ 2 ] As of March 2021, the number of persons with COVID-19 worldwide was approximately 115 million, with more than 2.5 million deaths. [ 3 ] COVID-19 has several clinical manifestations. The main presenting symptoms are fever and respiratory symptoms, such as cough, sputum production, and shortness of breath.…”